Polar Capital Holdings PLC Global Blood Therapeutics, Inc. Transaction History

Polar Capital Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $4.49 Million - $6.23 Million	175,000 Added 19.01%	1,095,810 $38 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $5.98 Million - $9.67 Million	-240,090 Reduced 20.68%	920,810 $27 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $10.5 Million - $15.3 Million	410,900 Added 54.79%	1,160,900 $29.6 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $9.74 Million - $12.7 Million	250,000 Added 50.0%	750,000 $30.6 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $18.8 Million - $31.9 Million	500,000 New	500,000 $21.7 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.